Gene Symbol | TLL2 |
---|---|
Entrez Gene | 7093 |
Alt Symbol | - |
Species | Human |
Gene Type | protein-coding |
Description | tolloid-like 2 |
Other Description | tolloid-like protein 2 |
Swissprots | Q2M1H1 Q9UQ00 A6NDK0 Q6PJN5 Q9Y6L7 |
Accessions | EAW49975 EAW49976 Q9Y6L7 AB023149 BAA76776 AF059516 AAD42979 AK026106 AW452288 BC013871 AAH13871 BC030548 BC111599 AAI11600 BC112341 AAI12342 BC112366 AAI12367 BC113577 AAI13578 DA716349 NM_012465 NP_036597 |
Function | Protease which specifically processes pro-lysyl oxidase. Required for the embryonic development. Predominant protease, which in the development, influences dorsal-ventral patterning and skeletogenesis. |
Subcellular Location | Secreted {ECO:0000305}. |
Human TLL2 full length protein - ab159714 from Abcam
|
||||||||||
TLL2 Antibody Blocking Peptide - LS-E916 from LifeSpan Bioscience
|
||||||||||
TLL2 Antibody Blocking Peptide - LS-E29550 from LifeSpan Bioscience
|
||||||||||
Recombinant Human TLL2 Protein - H00007093-P01 from Novus Biologicals
|
||||||||||
TLL2-Antibody-Center-Blocking-peptide - BP11319c from Abgent, a WuXi AppTec company
|
||||||||||
TLL2 - H00007093-P01-10 from Acris Antibodies
|
||||||||||
TLL2 - H00007093-P01-25 from Acris Antibodies
|
||||||||||
TLL2 fusion protein - Ag17009 from Proteintech Group
|
||||||||||
TLL2 fusion protein - Ag16209 from Proteintech Group
|
||||||||||
Recombinant Human TLL2, His-tagged - TLL2-3255H from Creative Biomart
|
||||||||||
TLL2-Antibody-N-term-Blocking-Peptide - BP7983a from Abgent, a WuXi AppTec company
|
||||||||||
TLL2 Peptide, Human - M34GP15996H from Creative Peptides
|